Cellebrite Appoints Shiven Ramji Chief

Cellebrite announced a leadership change on August 13, 2026. Cellebrite appointed Shiven Ramji, who joined as President, Products and Technology in May 2026, as CEO, succeeding Thomas E. Hogan as part of a planned transition.

What changed

Shiven Ramji was named Chief Executive Officer. Thomas E. Hogan, who joined Cellebrite as Executive Chairman in August 2023, became interim CEO in January 2025 and was appointed CEO in August 2025, was succeeded by Ramji as part of a planned transition.

Leader: Shiven Ramji
Role: Chief Executive Officer
Effective: Effective immediately
Announcement date: August 13, 2026

Leadership background

Ramji joined Cellebrite as President, Products and Technology in May 2026. Board Chairman Adam Clammer described him as having a product-first approach and a successful track record of building and growing businesses. Ramji will also be appointed to the company’s Board of Directors.

The mandate

Board Chairman Adam Clammer said Ramji is the right CEO for the company’s next chapter. Ramji said the company’s mission is helping customers accelerate investigations, uncover trusted intelligence, deliver justice and protect communities. He also said second-quarter ARR came in below the company’s expectations and that the company is taking action to improve execution going forward.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Cellebrite